This list is an analysis based on recent market events. It's not an investment recommendation.
About
VVT Med, Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and non-tumescent solutions for the treatment of varicose veins. Its product portfolio includes ScleroSafe and V-Block, which offer several competitive advantages over traditional treatments, such as shorter procedure times, reduced patient discomfort without the need for anesthesia, and faster recovery and visible results. The company was founded in 1969 and is headquartered in Vancouver, Canada.
The current price of VVTMF is $0.12 USD — it has decreased by -3.07% in the past 24 hours. Watch VVT Med stock price performance more closely on the chart.
What is VVT Med stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange VVT Med stocks are traded under the ticker VVTMF.
Is VVT Med stock price growing?▼
VVTMF stock has fallen by -3.07% compared to the previous week, the month change is a -3.07% fall, over the last year VVT Med has showed a -53% decrease.
What is VVT Med market cap?▼
Today VVT Med has the market capitalization of 8.71M
What is VVT Med revenue for the last year?▼
VVT Med revenue for the last year amounts to 89,000 USD.
What is VVT Med net income for the last year?▼
VVTMF net income for the last year is -3.94M USD.
How many employees does VVT Med have?▼
As of October 25, 2026, the company has 8 employees.